Smoking cessation in individuals with serious mental illness: A randomized controlled trial of two psychosocial interventions

Journal of Dual Diagnosis

Volumn 11, Issue 3-4, 2015, Pages 161-173

  Bennett, Melanie E ^a,b   Brown, Clayton H ^a,b   Li, Lan ^b   Himelhoch, Seth ^a,b   Bellack, Alan ^b   Dixon, Lisa ^a,c  

^a Education and Clinical Center   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c NewYork Presbyterian Hospital   (United States)

Author keywords

psychosocial interventions; RCT; serious mental illness; smoking cessation

Indexed keywords

ADULT; ARTICLE; BEHAVIOR CHANGE; BIPOLAR DISORDER; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HEALTH CARE; MENTAL HEALTH SERVICE; PEER GROUP; RANDOMIZED CONTROLLED TRIAL; REINFORCEMENT; SCHIZOPHRENIA; SELF CONCEPT; SMOKING CESSATION; BEHAVIOR THERAPY; COMPLICATION; MIDDLE AGED; PROCEDURES; PSYCHOLOGY; SMOKING; THERAPY; TREATMENT OUTCOME;

BEHAVIOR THERAPY; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; SELF EFFICACY; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 84951099090     PISSN: 15504263     EISSN: 15504271     Source Type: Journal    
DOI: 10.1080/15504263.2015.1104481     Document Type: Article

References (74)

1. Addington, J. (1998). Group treatment for smoking cessation among persons with schizophrenia. Psychiatric Services, 49, 925-928
2. Auquier, P., Lancon, C., Rouillon, F., Lader, M., & Holmes, C. (2006). Mortality in schizophrenia. Pharmacoepidemiology and Drug Safety, 15 (12), 873-879
3. Baker, A., Richmond, R., Haile, M., Lewin, T.J., Carr, V.J., Taylor, R.L.,. & Wilhelm, K. (2006). A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder. American Journal of Psychiatry, 163, 1934-1942
4. Bedfont Scientific U. (n.d.). EC50 Micro III Smokerlyzer Breath Carbon Monoxide Monitor. Medford: Bedfont Scientific Ltd Ed.
5. Bellack, A.S., Bennett, M.E., Gearon, J.S., Brown, C.H., & Yang, Y. (2006). A randomized clinical trial of a new behavioral intervention for drug abuse in people with severe and persistent mental illness. Archives of General Psychiatry, 63, 426-432
6. Bennett, M.E., Bellack, A.S., & Gearon, J.S. (2001). Treating substance abuse in schizophrenia: An initial report. Journal of Substance Abuse Treatment, 20, 163-175
7. Bennett, M.E., Dixon, L., & Dickerson, F. (2008,. November). Behavioral treatment for smoking cessation in serious and persistent mental illness. Presented at the 42nd annual meeting of the Association for the Advancement of Behavioral and Cognitive Therapies, Orlando, Florida
8. Bennett, M.E., Wilson, A.L., Genderson, M., & Saperstein, A.M. (2013). Smoking cessation in people with schizophrenia. Current Drug Abuse Reviews, 6 (3), 180-190
9. Bickel, W.K., Amass, L., Higgins, S.T., Badger, G.J., & Esch, R.A. (1997). Effects of adding behavioral treatment to opioid detoxification with buprenorphine. Journal of Consulting and Clinical Psychology, 65, 803-810
10. Brunette, M.F., Ferron, J.C., McHugo, G.J., Davis, K.E., Devitt, T.S., Wilkness, S.M., & Drake, R.E. (2011). An electronic decision support system to motivate people with severe mental illnesses to quit smoking. Psychiatric Services, 62 (4), 360-366. doi: 10.1176/appi.ps.62.4.360
11. Buchanan, R.W., Kreyenbuhl, J., Kelly, D.L., Noel, J.M., Boggs, D.L., Fischer, B.A.,. Keller, W. (2010). The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophrenia Bulletin, 36 (1), 71-93. doi: 10.1093/schbul/sbp116
12. Bushe, C.J., Taylor, M., & Haukka, J. (2010). Mortality in schizophrenia: A measurable clinical endpoint. Journal of Psychopharmacology, 24 (4 supplement), 17-25. doi: 10.1177/1359786810382468
13. Carney, C.P., & Jones, L.E. (2006). Medical comorbidity in women and men with bipolar disorders: A population-based controlled study. Psychosomatic Medicine, 68 (5), 684-691
14. Carney, C.P., Jones, L., & Woolson, R.F. (2006). Medical comorbidity in women and men with schizophrenia: A population-based controlled study. Journal of General Internal Medicine, 21 (11), 1133-1137
15. Cather, C., Dyer, M.A., Burrell, H.A., Hoeppner, B., Goff, D.C., & Evins, E.A. (2013). An open trial of relapse prevention therapy for smokers with schizophrenia. Journal of Dual Diagnosis, 9 (1), 87-93. doi: 10.1080/15504263.2012.749559
16. Centers for Disease Control and Prevention. (2014). Best Practices for Comprehensive Tobacco Control Programs-2014. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health
17. Compton, M.T., Daumit, G.L., & Druss, B.G. (2006). Cigarette smoking and overweight/obesity among individuals with serious mental illnesses: A preventive perspective. Harvard Review of Psychiatry, 14 (4), 212-222
18. Currie, S.R., Karltyn, J., Lussier, D., de Denus, E., Brown, D., & El-Guebaly, N. (2008). Outcome from a community-based smoking cessation program for persons with serious mental illness. Community Mental Health Journal, 44 (3), 187-194
19. Deegan, P.E., & Drake, R.E. (2006). Shared decision making and medication management in the recovery process. Psychiatric Services, 57, 1636-1639
20. Department of Health and Human Services, National Center for Health Statistics. (1998). The Third National Health and Nutrition Examination Survey 1988-94 (NHANES III). Hyattsville, MD: Center for Disease Control and Prevention
21. Department of Veterans Affairs, Veterans Health Administration. (2012). VHA DIRECTIVE 2012-002: Re-Engaging Veterans with Serious Mental Illness in Treatment. Washington, DC.
22. Dickerson, F., Bennett, M., Dixon, L., Burke, E., Vaughan, C., Delahanty, J., & DiClemente, C. (2011). Smoking cessation in persons with serious mental illness: The experience of successful quitters. Psychiatric Rehabilitation Journal, 34 (4), 311-316. doi: 10.2975/34.4.2011.311.316
23. Dickerson, F., Stallings, C., Origoni, A., Schroeder, J., Khushalani, S., & Yolken, R. (2013). Mortality in schizophrenia: Clinical and serological predictors. Schizophrenia Bulletin, 40 (4), 796-803. doi: 10.1093/schbul/sbt113
24. Dickerson, F., Stallings, C.R., Origoni, A.E., Vaughan, C., Khushalani, S., Schroeder, J., & Yolk, R.H. (2013). Cigarette smoking among persons with schizophrenia or bipolar disorder in routine clinical settings, 1999-2011. Psychiatric Services, 64 (1), 44-50. doi: 10.1176/appi.ps.201200143
25. DiClemente, C.C., Prochaska, J.O., & Gibertinin, M. (1985). Self-efficacy and the stages of self-change of smoking. Cognitive Therapy and Research, 9, 181-200
26. Dixon, L., Dickerson, F., Bellack, A., Bennett, M., Dickinson, D., Goldberg, R.,. Kreyenbuhl, J. (2010). The 2009 PORT psychosocial treatment recommendations and summary statement. Schizophrenia Bulletin, 36 (1), 48-70. doi: 10.1093/schbul/sbp115
27. Dixon, L., Medoff, D.R., Wohlheiter, K., DiClemente, C., Goldberg, R., Kreyenbuhl, J.,. Davin, C. (2007). Correlates of severity of smoking among persons with severe mental illness. American Journal on Addictions, 16 (2), 101-110
28. Drake, R.E., Mueser, K.T., & Brunette, M.F. (2007). Management of persons with co-occurring severe mental illness and substance use disorder: Program implications. World Psychiatry, 6 (3), 131-136
29. Duffy, S.A., Kilbourne, A.M., Austin, K.L., Dalack, G.W., Woltmann, E.M., Waxmonsky, J., & Noonan, D. (2012). Risk of smoking and receipt of cessation services among veterans with mental disorders. Psychiatric Services, 63 (4), 325-332. doi: 10.1176/appi.ps.201100097
30. Epstein, D.H., Hawkins, W.E., Covi, L., Umbricht, A., & Preston, K.L. (2003). Cognitive-behavioral therapy plus contingency management for cocaine use: Findings during treatment and across 12-month follow-up. Psychology of Addictive Behaviors, 17, 73-82
31. Esterberg, M.L., & Compton, M.T. (2005). Smoking behavior in persons with a schizophrenia-spectrum disorder: A qualitative investigation of the transtheoretical model. Social Science and Medicine, 61 (2), 293-303
32. Evins, A.E., Cather, C., & Laffer, A. (2015). Treatment of tobacco use disorder in smokers with serious mental illness: Toward clinical best practices. Harvard Review of Psychiatry, 23 (2), 90-98. doi: 10.1097/HRP.0000000000000063
33. Evins, A.E., Cather, C., Pratt, S.A., Pachas, G.N., Hoeppner, S.S., Goff, D.C.,. Schoenfeld, D.A. (2014). Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: A randomized clinical trial. JAMA: The Journal of the American Medical Association, 311 (2), 145-154. doi: 10.1001/jama.2013.285113
34. Ferron, J.C., Alterman, A., McHugo, G.J., Brunette, M.F., & Drake, R.E. (2009). A review of research on smoking cessation interventions for adults with schizophrenia spectrum disorders. Mental Health and Substance Abuse: Dual Diagnosis, 2 (1), 64-79. doi: 10.1080/17523280802593327
35. Fiore, M.C., Jaen, C.R., Baker, T.B., Bailey, W.C., Benowitz, N.L., Curry, S.J.,. Wewers, M.E. (2008). Treating tobacco use and dependence: 2008 update. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service. Retrieved from http://www.ahrq.gov/professionals/clinicians-providers/guidelines-recommendations/tobacco/clinicians/update/treating-tobacco-use08.pdf
36. George, T.P., Ziedonis, D.M., Feingold, A., Pepper, W.T., Satterburg, C.A., Winkel, J.,. Kosten, T.R. (2000). Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. American Journal of Psychiatry, 157, 1835-1842
37. Heatherton, T.F., Kozlowski, L.T., Frecker, R.C., Fagerström, K.O. (1991). The Fagerström Test for Nicotine Dependence: A revision of the Fagerström tolerance questionnaire. British Journal of Addictions, 86, 1119-1127
38. Hennekens, C.H., Hennekens, A.R., Hollar, D., & Casey, D.E. (2005). Schizophrenia and increased risks of cardiovascular disease. American Heart Journal, 150 (6), 1115-1121
39. Himelhoch, S., & Daumit, G. (2003). To whom do psychiatrists offer smoking-cessation counseling?. American Journal of Psychiatry, 160, 2228-2230
40. Himelhoch, S., Lehman, A., Kreyenbuhl, J., Daumit, G., Brown, C., & Dixon, L. (2004). Prevalence of chronic obstructive pulmonary disease among those with serious mental illness. American Journal of Psychiatry, 161, 2317-2319
41. Himelhoch, S., Riddle, J., & Goldman, H.H. (2014). Barriers to implementing evidence-based smoking cessation practices in nine community mental health sites. Psychiatric Services, 65 (1), 75-80. doi: 10.1176/appi.ps.201200247
42. Jeste, D.V., Gladsjo, J.A., Lindamer, L.A., & Lacro, J.P. (1996). Medical comorbidity in schizophrenia. Schizophrenia Bulletin, 22 (3), 413-430
43. Kelly, D.L., McMahon, R.P., Liu, F., Love, R.C., Wehring, H.J., Shim, J.C.,. Conley, R.R. (2010). Cardiovascular disease mortality in patients with chronic schizophrenia treated with clozapine: A retrospective cohort study. Journal of Clinical Psychiatry, 71, 304-311. doi: 10.4088/JCP.08m04718yel
44. Kelly, D.L., Raley, H., Lo, S., Wright, K., Moolchan, E., Feldman, S.,. Heishman, S. (2012). Perception of smoking risks and motivation to quit among nontreatment-seeking smokers with and without schizophrenia. Schizophrenia Bulletin, 38, 543-551. doi: 10.1093/schbul/sbq124
45. Kelly, D.L., Wehring, H.J., Linthicum, J., Feldman, S., McMahon, R.P., Love, R.C.,. Fowler, D.R. (2009). Cardiac-related findings at autopsy in people with severe mental illness treated with clozapine or risperidone. Schizophrenia Research, 107, 134-138. doi: 10.1016/j.schres.2008
46. Kreyenbuhl, J., Nossel, I.R., & Dixon, L.B. (2009). Disengagement from mental health treatment among individuals with schizophrenia and strategies for facilitating connections to care: A review of the literature. Schizophrenia Bulletin, 35 (4), 696-703. doi: 10.1093/schbul/sbp046
47. Lawn, S., & Campion, J. (2013). Achieving smoke-free mental health services: Lessons from the past decade of implementation research. International Journal of Environmental Research and Public Health, 10, 4224-4244. doi: 10.3390/ijerph10094224
48. Leonard, S., & Adams, C.E. (2006). Smoking cessation and schizophrenia. American Journal of Psychiatry, 163 (11), 1877
49. Little, R.J. A., & Rubin, D.B. (2002). Statistical analysis with missing data,. 2nd ed. Hoboken, NJ: Wiley
50. Lucksted, A., Dixon, L.B., & Sembly, J.B. (2000). A focus group pilot study of tobacco smoking among psychosocial rehabilitation clients. Psychiatric Services, 51, 1544-1548
51. Mann-Wrobel, M.C., Bennett, M.E., Weiner, E.E., Buchanan, R.W., & Ball, M.P. (2010). Smoking history and motivation to quit in smokers with schizophrenia in a smoking cessation program. Schizophrenia Research, 126 (1-3), 277-283. doi: 10.1016/j.schres.2010.10.030
52. Miller, B.J., Paschall, C.B., & Svendsen, D.P. (2006). Mortality and medical comorbidity among patients with serious mental illness. Psychiatric Services, 57 (1), 1482-1487
53. Moore, D., Aveyard, P., Connock, M., Wang, D., Fry-Smith, A., & Barton, P. (2009). Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: Systematic review and meta-Analysis. British Medical Journal, 338, 1024. doi: 10.1136/bmj.b1024
54. Muir-Cochrane, E. (2006). Medical comorbidity risk factors and barriers to care for people with schizophrenia. Journal of Psychiatric Mental Health Nursing, 13 (4), 447-452
55. Newcomer, J.W. (2006). Medical risk in patients with bipolar disorder and schizophrenia. Journal of Clinical Psychiatry, 67 (11), e16
56. Overall, J.E., & Gorham, D.R. (1962). The brief psychiatric rating scale. Psychological Reports, 10, 799-812
57. Prochaska, J.J. (2010a). Failure to treat tobacco use in mental health and addiction treatment settings: A form of harm reduction? Drug and Alcohol Dependence, 110 (3), 177-182. doi: 0.1016/j.drugalcdep.2010.03.002
58. Prochaska, J.J. (2010b). Integrating tobacco treatment into mental health settings. JAMA: The Journal of the American Medical Association, 304 (22), 2534-2535. doi: 10.1001/jama.2010.1759
59. Ratschen, E., Britton, J., & McNeill, A. (2011). The smoking culture in psychiatry: Time for change. British Journal of Psychiatry, 198, 6-7. doi: 10.1192/bjp.bp.110.081372
60. Selzer, M.L. (1971). The Michigan Alcoholism Screening Test: The quest for a new diagnostic instrument. American Journal of Psychiatry, 127, 1653-1658
61. Shim, J.C., Jung, D.U., Jung, S.S., Seo, Y.S., Cho, D.M., Lee, J.H.,. Kelly, D.L. (2012). Adjunctive varenicline treatment with antipsychotic medications for cognitive impairments in people with schizophrenia: A randomized double-blind placebo-controlled trial. Neuropsychopharmacology, 37 (3), 660-668. doi: 10.1038/npp.2011.238
62. Sigmon, S.C., & Patrick, M.E. (2012). The use of financial incentives in promoting smoking cessation. Preventative Medicine, 55 (Suppl), S24-S32. doi: 10.1016/j.ypmed.2012.04.007
63. Skinner, H. (1982). The Drug Abuse Screening Test. Addictive Behaviors, 7, 363-371
64. Smith, P.H., Mazure, C.M., & McKee, S.A. (2014). Smoking and mental illness in the U.S. population. Tobacco Control, 23, 147-153. doi: 10.1136/tobaccocontrol-2013-051466
65. Sokal, J., Messias, E., Dickeron, F.B., Kreyenbuhl, J., Brown, C.H., Goldberg, R.W., & Dixon, L.B. (2004). Comorbidity of medical illnesses among adults with serious mental illness who are receiving community psychiatric services. Journal of Nervous and Mental Disease, 192, 421-427
66. Stitzer, M.L. (1999). Combined behavioral and pharmacological treatments for SC. Nicotine and Tobacco Research, 1 (Suppl 2), S181-187
67. Tsoi, D.T., Porwal, M., & Webster, A.C. (2013a). Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database of Systematic Reviews, 2, CD007253. doi: 10.1002/14651858.CD007253
68. Tsoi, D.T., Porwal, M., & Webster, A.C. (2013b). Efficacy and safety of bupropion for smoking cessation and reduction in schizophrenia: Systematic review and meta-Analysis. British Journal of Psychiatry, 196 (5), 346-353. doi: 10.1192/bjp.bp.109.066019
69. Weiner, E., Ball, M.P., Summerfelt, A., Gold, J., & Buchanan, R.W. (2001). Effects of sustained-release bupropion and supportive group therapy on cigarette smoking in patients with schizophrenia. American Journal of Psychiatry, 158 (4), 635-637
70. Williams, J.M., Anthenelli, R.M., Morris, C.D., Treadow, J., Thompson, J.R., Yunis, C., & George, T.P. (2012). A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder. Journal of Clinical Psychiatry, 73 (5), 654-660. doi: 10.4088/JCP.11m07522
71. Williams, J.M., Steinberg, M.L., Griffiths, K.G., & Cooperman, N. (2013). Smokers with behavioral health comorbidity should be designated a Tobacco Use Disparity Group. American Journal of Public Health, 103, 1549-1555. doi: 10.2105/AJPH.2013.301232
72. Williams, J.M., Steinberg, M.L., Zimmermann, M.H., Gandhi, K.K., Stipelman, B., Budsock, P.D., & Ziedonis, D.M. (2010). Comparison of two intensities of tobacco dependence counseling in schizophrenia and schizoaffective disorder. Journal of Substance Abuse Treatment, 38 (4), 384-393. doi: 10.1016/j.jsat.2010.03.006
73. Ziedonis, D.M., & George, T.P. (1997). Schizophrenia and nicotine use: Report of a pilot smoking cessation program and review of neurobiological and clinical issues. Schizophrenia Bulletin, 23, 247-254
74. Ziedonis, D., Hitsman, B., Beckham, J.C., Zvolensky, M., Adler, L.E., Audrain-McGovern, J.,. Riley, W.T. (2008). Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine and Tobacco Research, 10 (12), 1691-1715. doi: 10.1080/14622200802443569